carbidopa

Carbidopa An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.

Molecular Formula: C₁₀H₁₄N₂O₄

InChI: InChI=1/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/f/h15H

InChIKey: InChIKey=TZFNLOMSOLWIDK-YAQRNVERCO
SMILES: CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN

Names:
    adjunct to levodopa in parkinsonism
    carbidopa
    3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methyl-propanoic acid

Registries:
    PubChem CID 2563
    PubChem ID 8149837